Mesenchymal stromal cells engage complement and complement receptor bearing innate effector cells to modulate immune responses - Wikidata - awgldk - TriplyDB

Mesenchymal stromal cells engage complement and complement receptor bearing innate effector cells to modulate immune responses

Mesenchymal stromal cells engage complement and complement receptor bearing innate effector cells to modulate immune responses

http://www.wikidata.org/entity/Q33958064

about

Genetic Engineering of Mesenchymal Stem Cells to Induce Their Migration and Survival Complement activation in the context of stem cells and tissue repair Mesenchymal stem cells: immune evasive, not immune privileged Activation, homing, and role of the mesenchymal stem cells in the inflammatory environment How stem cells speak with host immune cells in inflammatory brain diseases Mesenchymal stem cells engineered to inhibit complement-mediated damage.Do cryopreserved mesenchymal stromal cells display impaired immunomodulatory and therapeutic properties?Human bone marrow stromal cell confluence: effects on cell characteristics and methods of assessment.In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome.Mesenchymal stromal cells in transplantation rejection and tolerance.Rat adipose-derived stem cells express low level of α-Gal and are dependent on CD59 for protection from human xenoantibody and complement-mediated lysis Safety of Intraperitoneal Injection of Adipose Tissue-Derived Autologous Mesenchymal Stem Cells in Cats.Complement-triggered pathways orchestrate regenerative responses throughout phylogenesis.Tissue-engineered airway: a regenerative solution.Mesenchymal stromal cells for cell therapy: besides supporting hematopoiesis.Mechanisms of mesenchymal stromal cell immunomodulation.Regenerative medicine: prospects for the treatment of inflammatory bowel disease.Stromal cells-are they really useful for GVHD?Targeted inhibition of osteosarcoma tumor growth by bone marrow-derived mesenchymal stem cells expressing cytosine deaminase/5-fluorocytosine in tumor-bearing mice.In vivo immune interactions of multipotent stromal cells underlie their long-lasting pain-relieving effect Local Inhibition of Complement Improves Mesenchymal Stem Cell Viability and Function After Administration Mesenchymal stromal cells from pooled mononuclear cells of multiple bone marrow donors as rescue therapy in pediatric severe steroid-refractory graft-versus-host disease: a multicenter survey.The role of human umbilical cord tissue-derived mesenchymal stromal cells (UCX®) in the treatment of inflammatory arthritis.Human fibroblast-derived extracellular matrix constructs for bone tissue engineering applications.Cryopreserved or Fresh Mesenchymal Stromal Cells: Only a Matter of Taste or Key to Unleash the Full Clinical Potential of MSC Therapy?Bone repair using periodontal ligament progenitor cell-seeded constructs.Peripheral nerve repair with cultured schwann cells: getting closer to the clinics.Localization of Mesenchymal Stromal Cells Dictates Their Immune or Proinflammatory Effects in Kidney Transplantation Clinical Cellular Therapeutics Accelerate Clot Formation

P2860

Q26744561-9548603D-B4BE-4308-9376-2BBA603C6195 Q26782203-699EFDAE-448B-47E9-B1BC-1A0231BD9D26 Q27003371-3EEA356E-E641-4BCA-BEB9-C892C7D9A0DC Q28067094-CDE6AC60-C448-4A87-AD68-95AD93BACA11 Q33776557-D04AEFA4-C3C5-43AA-9BD8-A0A6DDA96EF1 Q34653955-81259626-93BC-4D05-A6FA-0D5F41A59DD1 Q35240062-B6CCB712-9091-4F57-B3EB-FC9BE8DB89D8 Q35706934-18ECBD57-A7C1-4BEF-B5C9-DCAA9F175D59 Q36067836-469A413C-F02D-43D2-9469-62AAD971C71B Q36786630-24B3CF6C-6E42-4B11-AFA0-086727B07141 Q36964074-5FF8C660-31F6-4B7A-A9FE-4FE589791952 Q37020401-E63D6FAB-C205-461D-82CE-D146FDFFE77B Q37576523-663446CE-EF3E-48DE-96D2-1DB655817ACF Q37963177-677CEEEC-77B8-4397-96CF-E30BFBC109CD Q37970019-555FDA96-D36F-4FFE-8A87-EE3C69B1AE85 Q38054535-F1002713-9CB4-4D59-8121-1219DE774F7E Q38133660-C543941E-1279-45C4-986A-E602C650CC01 Q38181957-639AE4DD-83A4-4B16-879C-25F1CFA400F0 Q38895289-F36D3C66-880B-4101-A882-454C9BF92ADD Q39150505-BD5EC805-1D6B-4BC3-A1A7-DB4EE75EE2D6 Q39633236-ABC60E86-FD22-46C6-9288-E3D001721367 Q40756307-7121EFB3-2A3B-4FCE-A128-D1E0D8765D16 Q41972955-CA2CA586-331C-4B58-BD3D-F33F186C3516 Q46288680-B98F5B55-1318-4FF4-B883-1A1D8CF11625 Q50224283-BA6C1B3E-A841-45B5-9E12-8EAC591E1B73 Q50244858-C4325BE5-8269-47CF-8AF3-92E624B64F66 Q52626491-6428A004-7DB0-4E5E-A93C-04C0BEE415F2 Q57701908-6F0BF1F4-6399-40EF-A758-CDA23E393ECD Q58804089-EDB6E18B-0771-44A9-88CA-5A0BE185CC2A

P2860

Mesenchymal stromal cells engage complement and complement receptor bearing innate effector cells to modulate immune responses

http://www.wikidata.org/entity/Q33958064

description

2011 nî lūn-bûn

@nan

2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Mesenchymal stromal cells enga ...... s to modulate immune responses

@ast

Mesenchymal stromal cells enga ...... s to modulate immune responses

@en

type

label

Mesenchymal stromal cells enga ...... s to modulate immune responses

@ast

Mesenchymal stromal cells enga ...... s to modulate immune responses

@en

prefLabel

Mesenchymal stromal cells enga ...... s to modulate immune responses

@ast

Mesenchymal stromal cells enga ...... s to modulate immune responses

@en

P1433

Q33958064-47505932-EB94-4473-8D4C-7E22867DFE1F

P1476

Q33958064-8A4B2C83-8D58-458D-AB6B-9A7BD125C157

P2093

Q33958064-13746249-0FB2-4A51-B907-145B416B3279

Q33958064-234200ED-B371-4604-8B67-D12915B560BB

Q33958064-3BA84910-3A09-46E9-B3B5-1E810FA7AEA4

Q33958064-41F6822F-AAAD-4DF8-A1A4-522E30581544

Q33958064-56DE077D-534C-4634-B114-4A520A3ED042

Q33958064-AD6C982E-6B66-4410-A3E0-F5B4C81BF0BB

Q33958064-B27204D6-E597-45AF-A6AC-2CEF4A87421D

Q33958064-E8E520F2-C4CC-4755-B8DE-89E19FC7C73C

Q33958064-FBC954E9-CC0F-422E-B7B3-8C9C428D89CA

Q33958064-FF5223A6-6492-4FCA-BFE8-F1EA5FA64A70

P2860

Q33958064-0055214D-B43B-44B5-AB5B-D0220B2C2296

Q33958064-0FA32118-D219-44D5-A2FE-537AE95E67DF

Q33958064-12DA9EBB-3770-487C-881C-BDF4FDF51EF1

Q33958064-15B67580-0A0D-4539-A876-93D9FC2F7F7F

Q33958064-1AFAD031-AA7B-42AE-AFD2-FD61C4FFD931

Q33958064-28ECFF45-67E5-402C-A67A-99261F68CA4C

Q33958064-393B1C0B-1B51-4D49-8955-04DDBDE6F3FF

Q33958064-42955172-4CE2-4851-8CE3-4FC36D0A91A5

Q33958064-45ABAFDA-DCFF-4EC1-BEA3-3AEAC580816D

Q33958064-45CA73DA-2378-4DF6-9774-E2E493CCACA8

P304

Q33958064-B7139647-A53D-4509-9B15-286A1B3EF72C

P31

Q33958064-471597B1-CAA0-4CB8-AB55-A55D2BFA4F9B

P356

Q33958064-73FCB9EE-AB9F-4087-8734-9078F726A429

P407

Q33958064-F948D140-CBDF-4410-B7BA-A784271A094D

P433

Q33958064-A166943A-9193-4484-96F1-FA2CB270C411

P478

Q33958064-1C92B21C-0D7E-48F9-88E0-FDFCD5892A22

P50

Q33958064-3C546CCE-D891-4ECB-9F87-083154916D1C

Q33958064-98B329FD-66E6-4821-AA39-6955EA2D69FA

Q33958064-D537482E-DDC8-4426-A8DB-F3D57C6DA081

P577

Q33958064-92CE2C51-D6DD-4CF1-89C1-0A9CB779953D

P5875

Q33958064-2B5459EB-A414-4DC8-9F49-03A8A09098FD

P698

Q33958064-29376A68-6C3C-40D6-874D-D019551F40EC

P932

Q33958064-3C451544-F902-4C90-A156-577F70BBFC0F

P356

JOURNAL.PONE.0021703

P1433

P1476

Mesenchymal stromal cells enga ...... s to modulate immune responses

@en

P2093

Berit Sundberg

http://www.w3.org/2001/XMLSchema#string

Dimitrios Mougiakakos

http://www.w3.org/2001/XMLSchema#string

Graciela Elgue

http://www.w3.org/2001/XMLSchema#string

Ida Rasmusson-Duprez

http://www.w3.org/2001/XMLSchema#string

Katarina Le Blanc

http://www.w3.org/2001/XMLSchema#string

Kristina Nilsson-Ekdahl

http://www.w3.org/2001/XMLSchema#string

Lena Lönnies

http://www.w3.org/2001/XMLSchema#string

Lena von Bahr

http://www.w3.org/2001/XMLSchema#string

Olle Ringdén

http://www.w3.org/2001/XMLSchema#string

Regina Jitschin

http://www.w3.org/2001/XMLSchema#string

P2860

Structures of complement component C3 provide insights into the function and evolution of immunity

A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V

Mesenchymal stem cells in health and disease

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production

Immunosuppressive strategies that are mediated by tumor cells

Why are MSCs therapeutic? New data: new insight.

Cancer and complement.

Mesenchymal stem cell therapy: Two steps forward, one step back

Complement-targeted therapeutics

P304

e21703

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0021703

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

John D. Lambris

P577

2011-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51484557

http://www.w3.org/2001/XMLSchema#string

P698

21747949

http://www.w3.org/2001/XMLSchema#string

P932

3128611

http://www.w3.org/2001/XMLSchema#string